Cargando…

COVID-19 mRNA Vaccine-induced Immunization Stress-Related Response (ISRR) and Anaphylaxis: An Early Look at COVAAR Clinical Outcomes

Detalles Bibliográficos
Autores principales:	Khalid, Muhammad, Utoh, Joanna, Zektser, Ellen, Guerrerio, Pamela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Mosby, Inc. 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9895905/ http://dx.doi.org/10.1016/j.jaci.2022.12.687

Ejemplares similares

The conundrum of COVID-19 mRNA vaccine–induced anaphylaxis
por: Khalid, Muhammad Bilal, et al.
Publicado: (2022)

Indole Sensing Regulator (IsrR) Promotes Virulence Gene Expression in Enteric Pathogens
por: Kumar, Aman, et al.
Publicado: (2022)

Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines
por: Risma, Kimberly A., et al.
Publicado: (2021)

COVID-19 mRNA vaccines: acute allergic reaction and anaphylaxis
Publicado: (2021)

mRNA 1273: Anaphylaxis: case report
Publicado: (2021)

May polyethylene glycol be the cause of anaphylaxis to mRNA COVID-19 vaccines?()
por: Giavina-Bianchi, Pedro, et al.
Publicado: (2021)

Anaphylaxis associated with the mRNA COVID-19 vaccines: Approach to allergy investigation
por: Erdeljic Turk, Viktorija
Publicado: (2021)

Sex differences in the incidence of anaphylaxis to LNP-mRNA COVID-19 vaccines
por: Somiya, Masaharu, et al.
Publicado: (2021)

mRNA COVID-19 Vaccine Anaphylaxis: Epidemiology, Risk Factors, and Evaluation
por: Jaggers, Jordon, et al.
Publicado: (2023)

Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination
por: Zhou, Zhao-Hua, et al.
Publicado: (2023)

Successful mRNA COVID-19 vaccination in a patient with a history of severe polyethylene glycol anaphylaxis
por: Li, Daniel H., et al.
Publicado: (2022)

Anaphylaxis induced by mRNA COVID-19 vaccines: follow-up and booster dose after previous desensitization
por: AlOtaibi, Ibtihal, et al.
Publicado: (2023)

Successful Desensitization to mRNA COVID-19 Vaccine in a Case Series of Patients With a History of Anaphylaxis to the First Vaccine Dose
por: AlMuhizi, Faisal, et al.
Publicado: (2022)

Anaphylaxis to Pfizer/BioNTech mRNA COVID-19 Vaccine in a Patient With Clinically Confirmed PEG Allergy
por: McSweeney, Morgan D., et al.
Publicado: (2021)

Anaphylaxis rates following mRNA COVID-19 vaccination in children and adolescents: Analysis of data reported to EudraVigilance
por: Maltezou, Helena C., et al.
Publicado: (2023)

Anaphylaxis to additives in vaccines
por: Mahler, Vera, et al.
Publicado: (2022)

mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis
por: Rama, Tiago Azenha, et al.
Publicado: (2021)

Innate immune mechanisms of mRNA vaccines
por: Verbeke, Rein, et al.
Publicado: (2022)

REVISITING HYPERSENSITIVITY REACTIONS TO THE MRNA COVID-19 VACCINE: TOLERANCE AFTER PREVIOUS HISTORY OF ANAPHYLAXIS
por: AlOtaibi, I., et al.
Publicado: (2022)

Immune Response to COVID-19 mRNA Vaccine—A Pilot Study
por: Lange, Andrzej, et al.
Publicado: (2021)

THE SIGNIFICANCE OF ANAPHYLAXIS IN PNEUMOCOCCUS IMMUNITY
por: Mackenzie, George M.
Publicado: (1925)

Influenza Viruses: Innate Immunity and mRNA Vaccines
por: Lee, SangJoon, et al.
Publicado: (2021)

M013 SUCCESSFUL FOUR-STEP GRADED-DOSE ADMINISTRATION TO THE PFIZER-MRNA SARS-COV-2 VACCINE IN A PATIENT WITH PREVIOUS ANAPHYLAXIS
por: Morgenstern-Kaplan, D., et al.
Publicado: (2021)

Food allergy and anaphylaxis – 2051. Economic burden of anaphylaxis in the United States
por: Wolf, Ray, et al.
Publicado: (2013)

A Fresh Look at Huntingtin mRNA Processing in Huntington’s Disease
por: Romo, Lindsay, et al.
Publicado: (2018)

SARS-CoV-2 mRNA vaccination and subsequent herpes zoster: Possible immune reconstitution by mRNA vaccination
por: Ota, Mitsuhito
Publicado: (2022)

Recent Updates on mRNA Vaccines
por: Sydow, Emily, et al.
Publicado: (2022)

Vaccination and anaphylaxis: a forensic perspective
por: Palmiere, Cristian, et al.
Publicado: (2017)

COVID-19 vaccin et anaphylaxie()
por: Joob, B., et al.
Publicado: (2021)

Anaphylaxis after vaccination for cats in Japan
por: YOSHIDA, Megumi, et al.
Publicado: (2021)

Cumulative Adverse Event Reporting of Anaphylaxis After mRNA COVID-19 Vaccine (Pfizer-BioNTech) Injections in Japan: The First-Month Report
por: Iguchi, Toyotaka, et al.
Publicado: (2021)

Study of humoral and cellular immunity in vaccinated with mRNA‐1273
por: Gutiérrez‐Bautista, Juan Francisco, et al.
Publicado: (2022)

HIV and Messenger RNA (mRNA) Vaccine
por: Khalid, Khizer, et al.
Publicado: (2021)

DIAGNOSING PERICARDITIS DUE TO COVID-19 VACCINATION
por: Zektser, Yuliya, et al.
Publicado: (2022)

COVID-19 vaccine-associated anaphylaxis: A statement of the World Allergy Organization Anaphylaxis Committee
por: Turner, Paul J., et al.
Publicado: (2021)

mRNA as a Therapeutics: Understanding mRNA Vaccines
por: Oğuz, Ferdi, et al.
Publicado: (2022)

mRNA Vaccine Platform: mRNA Production and Delivery
por: Litvinova, V. R., et al.
Publicado: (2023)

The Importance of a Timely Second Dose of the 2021 COVID-19 mRNA Vaccine Depends on the Protection Afforded by a First Dose and Subsequent Risk of Anaphylaxis
por: Shaker, Marcus, et al.
Publicado: (2021)

Heparin-induced Anaphylaxis shock
por: Mohamed, Anas, et al.
Publicado: (2023)

mRNA-Based Vaccine Designing against Epstein-Barr Virus to Induce an Immune Response Using Immunoinformatic and Molecular Modelling Approaches
por: Althurwi, Hassan N., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_30dnu3d2hs4tu2gtsolbi64evo